Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Completion of adjuvant therapy in patients with resected pancreatic cancer.

DePeralta DK, Ogami T, Zhou JM, Schell MJ, Powers BD, Hodul PJ, Malafa MP, Fleming JB.

HPB (Oxford). 2019 Sep 25. pii: S1365-182X(19)30622-7. doi: 10.1016/j.hpb.2019.07.008. [Epub ahead of print]

PMID:
31563326
2.

Vitamin E δ-tocotrienol sensitizes human pancreatic cancer cells to TRAIL-induced apoptosis through proteasome-mediated down-regulation of c-FLIPs.

Francois RA, Zhang A, Husain K, Wang C, Hutchinson S, Kongnyuy M, Batra SK, Coppola D, Sebti SM, Malafa MP.

Cancer Cell Int. 2019 Jul 22;19:189. doi: 10.1186/s12935-019-0876-0. eCollection 2019.

3.

Chemoprevention of Azoxymethane-induced Colon Carcinogenesis by Delta-Tocotrienol.

Husain K, Zhang A, Shivers S, Davis-Yadley A, Coppola D, Yang CS, Malafa MP.

Cancer Prev Res (Phila). 2019 Jun;12(6):357-366. doi: 10.1158/1940-6207.CAPR-18-0290. Epub 2019 Apr 2.

PMID:
30940630
4.

Pancreatic Adenocarcinoma, Version 1.2019.

Tempero MA, Malafa MP, Chiorean EG, Czito B, Scaife C, Narang AK, Fountzilas C, Wolpin BM, Al-Hawary M, Asbun H, Behrman SW, Benson AB, Binder E, Cardin DB, Cha C, Chung V, Dillhoff M, Dotan E, Ferrone CR, Fisher G, Hardacre J, Hawkins WG, Ko AH, LoConte N, Lowy AM, Moravek C, Nakakura EK, O'Reilly EM, Obando J, Reddy S, Thayer S, Wolff RA, Burns JL, Zuccarino-Catania G.

J Natl Compr Canc Netw. 2019 Mar 1;17(3):202-210. doi: 10.6004/jnccn.2019.0014.

PMID:
30865919
5.

Recognition of Tumor Invasion of a Pancreatic Head Biliary Stent During Stereotactic Body Radiation Therapy.

Song E, Segarra D, Latifi K, Leuthold S, Belinc D, Pena L, Malafa MP, Frakes JM, Hoffe SE.

Pract Radiat Oncol. 2019 May;9(3):132-135. doi: 10.1016/j.prro.2019.01.008. Epub 2019 Jan 29. No abstract available.

PMID:
30708132
6.

Identification of nonalcoholic fatty liver disease following pancreatectomy for noninvasive intraductal papillary mucinous neoplasm.

Luu C, Thapa R, Rose T, Woo K, Jeong D, Thomas K, Chen DT, Friedman M, Malafa MP, Hodul PJ.

Int J Surg. 2018 Oct;58:46-49. doi: 10.1016/j.ijsu.2018.09.002. Epub 2018 Sep 12.

PMID:
30218781
7.

Adjuvant radiation provides survival benefit for resected pancreatic adenocarcinomas of the tail.

Jin WH, Hoffe SE, Shridhar R, Strom T, Venkat P, Springett GM, Hodul PJ, Pimiento JM, Meredith KL, Malafa MP, Frakes JM.

J Gastrointest Oncol. 2018 Jun;9(3):487-494. doi: 10.21037/jgo.2018.02.02.

8.

EGFR L861Q Mutation in a Metastatic Solid-pseudopapillary Neoplasm of the Pancreas.

Neill KG, Saller J, Al Diffalha S, Centeno BA, Malafa MP, Coppola D.

Cancer Genomics Proteomics. 2018 May-Jun;15(3):201-205.

9.

Impact of sarcopenia in borderline resectable and locally advanced pancreatic cancer patients receiving stereotactic body radiation therapy.

Jin WH, Mellon EA, Frakes JM, Murimwa GZ, Hodul PJ, Pimiento JM, Malafa MP, Hoffe SE.

J Gastrointest Oncol. 2018 Feb;9(1):24-34. doi: 10.21037/jgo.2017.09.13.

10.

Outcomes of adjuvant radiotherapy and lymph node resection in elderly patients with pancreatic cancer treated with surgery and chemotherapy.

Frakes J, Mellon EA, Springett GM, Hodul P, Malafa MP, Fulp WJ, Zhao X, Hoffe SE, Shridhar R, Meredith KL.

J Gastrointest Oncol. 2017 Oct;8(5):758-765. doi: 10.21037/jgo.2017.08.05.

11.

Multimodality Management of "Borderline Resectable" Pancreatic Neuroendocrine Tumors: Report of a Single-Institution Experience.

Ambe CM, Nguyen P, Centeno BA, Choi J, Strosberg J, Kvols L, Hodul P, Hoffe S, Malafa MP.

Cancer Control. 2017 Oct-Dec;24(5):1073274817729076. doi: 10.1177/1073274817729076.

12.

Linc-ing Circulating Long Non-coding RNAs to the Diagnosis and Malignant Prediction of Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Permuth JB, Chen DT, Yoder SJ, Li J, Smith AT, Choi JW, Kim J, Balagurunathan Y, Jiang K, Coppola D, Centeno BA, Klapman J, Hodul P, Karreth FA, Trevino JG, Merchant N, Magliocco A, Malafa MP, Gillies R.

Sci Rep. 2017 Sep 5;7(1):10484. doi: 10.1038/s41598-017-09754-5.

13.

Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Tempero MA, Malafa MP, Al-Hawary M, Asbun H, Bain A, Behrman SW, Benson AB 3rd, Binder E, Cardin DB, Cha C, Chiorean EG, Chung V, Czito B, Dillhoff M, Dotan E, Ferrone CR, Hardacre J, Hawkins WG, Herman J, Ko AH, Komanduri S, Koong A, LoConte N, Lowy AM, Moravek C, Nakakura EK, O'Reilly EM, Obando J, Reddy S, Scaife C, Thayer S, Weekes CD, Wolff RA, Wolpin BM, Burns J, Darlow S.

J Natl Compr Canc Netw. 2017 Aug;15(8):1028-1061. doi: 10.6004/jnccn.2017.0131.

PMID:
28784865
14.

δ-Tocotrienol, a natural form of vitamin E, inhibits pancreatic cancer stem-like cells and prevents pancreatic cancer metastasis.

Husain K, Centeno BA, Coppola D, Trevino J, Sebti SM, Malafa MP.

Oncotarget. 2017 May 9;8(19):31554-31567. doi: 10.18632/oncotarget.15767.

15.

Endoscopic ultrasonography complements computed tomography in predicting portal or superior mesenteric vein resection in patients with borderline resectable pancreatic carcinoma.

Glazer ES, Rashid OM, Klapman JB, Harris CL, Hodul PJ, Pimiento JM, Malafa MP.

Pancreatology. 2017 Jan - Feb;17(1):130-134. doi: 10.1016/j.pan.2016.12.001. Epub 2016 Dec 5.

PMID:
28043760
16.

Expression of CAS/CSE1L, the Cellular Apoptosis Susceptibility Protein, Correlates With Neoplastic Progression in Barrett's Esophagus.

Jiang K, Neill K, Cowden D, Klapman J, Eschrich S, Pimiento J, Malafa MP, Coppola D.

Appl Immunohistochem Mol Morphol. 2018 Sep;26(8):552-556. doi: 10.1097/PAI.0000000000000464.

17.

TGFβ1 overexpression is associated with improved survival and low tumor cell proliferation in patients with early-stage pancreatic ductal adenocarcinoma.

Glazer ES, Welsh E, Pimiento JM, Teer JK, Malafa MP.

Oncotarget. 2017 Jan 3;8(1):999-1006. doi: 10.18632/oncotarget.13533.

18.

Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapy.

Mellon EA, Jin WH, Frakes JM, Centeno BA, Strom TJ, Springett GM, Malafa MP, Shridhar R, Hodul PJ, Hoffe SE.

Acta Oncol. 2017 Mar;56(3):391-397. doi: 10.1080/0284186X.2016.1256497. Epub 2016 Nov 25.

PMID:
27885876
19.

Systematic Review and Case Series Report of Acinar Cell Carcinoma of the Pancreas.

Glazer ES, Neill KG, Frakes JM, Coppola D, Hodul PJ, Hoffe SE, Pimiento JM, Springett GM, Malafa MP.

Cancer Control. 2016 Oct;23(4):446-454. Review.

PMID:
27842335
20.

Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.

Glazer ES, Rashid OM, Pimiento JM, Hodul PJ, Malafa MP.

Surgery. 2016 Nov;160(5):1288-1293. doi: 10.1016/j.surg.2016.04.039. Epub 2016 Jul 20.

21.

Her-2 Expression in Gastroesophageal Intestinal Metaplasia, Dysplasia, and Adenocarcinoma.

Almhanna K, Rosa M, Henderson-Jackson E, Jiang K, Shamekh R, Sayegh Z, Malafa MP, Coppola D.

Appl Immunohistochem Mol Morphol. 2016 Oct;24(9):633-638.

PMID:
26186253
22.

Favorable perioperative outcomes after resection of borderline resectable pancreatic cancer treated with neoadjuvant stereotactic radiation and chemotherapy compared with upfront pancreatectomy for resectable cancer.

Mellon EA, Strom TJ, Hoffe SE, Frakes JM, Springett GM, Hodul PJ, Malafa MP, Chuong MD, Shridhar R.

J Gastrointest Oncol. 2016 Aug;7(4):547-55. doi: 10.21037/jgo.2016.03.15.

23.

Knockdown of CSE1L Gene in Colorectal Cancer Reduces Tumorigenesis in Vitro.

Pimiento JM, Neill KG, Henderson-Jackson E, Eschrich SA, Chen DT, Husain K, Shibata D, Coppola D, Malafa MP.

Am J Pathol. 2016 Oct;186(10):2761-8. doi: 10.1016/j.ajpath.2016.06.016. Epub 2016 Aug 10.

24.

Pharmacokinetics and safety of vitamin E δ-tocotrienol after single and multiple doses in healthy subjects with measurement of vitamin E metabolites.

Mahipal A, Klapman J, Vignesh S, Yang CS, Neuger A, Chen DT, Malafa MP.

Cancer Chemother Pharmacol. 2016 Jul;78(1):157-65. doi: 10.1007/s00280-016-3048-0. Epub 2016 Jun 8.

25.

Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer.

Chuong MD, Frakes JM, Figura N, Hoffe SE, Shridhar R, Mellon EA, Hodul PJ, Malafa MP, Springett GM, Centeno BA.

J Gastrointest Oncol. 2016 Apr;7(2):221-7. doi: 10.3978/j.issn.2078-6891.2015.075.

26.

Advances in the Endoscopic Diagnosis of Barrett Esophagus.

Davis-Yadley AH, Neill KG, Malafa MP, Pena LR.

Cancer Control. 2016 Jan;23(1):67-77. Review.

PMID:
27009460
27.

Effect of Metformin Use on Survival in Resectable Pancreatic Cancer: A Single-Institution Experience and Review of the Literature.

Ambe CM, Mahipal A, Fulp J, Chen L, Malafa MP.

PLoS One. 2016 Mar 11;11(3):e0151632. doi: 10.1371/journal.pone.0151632. eCollection 2016.

28.

A Phase I Safety, Pharmacokinetic, and Pharmacodynamic Presurgical Trial of Vitamin E δ-tocotrienol in Patients with Pancreatic Ductal Neoplasia.

Springett GM, Husain K, Neuger A, Centeno B, Chen DT, Hutchinson TZ, Lush RM, Sebti S, Malafa MP.

EBioMedicine. 2015 Nov 14;2(12):1987-95. doi: 10.1016/j.ebiom.2015.11.025. eCollection 2015 Dec.

29.

Adenomatous polyposis coli (APC) regulates miR17-92 cluster through β-catenin pathway in colorectal cancer.

Li Y, Lauriola M, Kim D, Francesconi M, D'Uva G, Shibata D, Malafa MP, Yeatman TJ, Coppola D, Solmi R, Cheng JQ.

Oncogene. 2016 Sep 1;35(35):4558-4568. doi: 10.1038/onc.2015.522. Epub 2016 Jan 25.

30.

Increased Expression of the Glucose Transporter Type 1 Gene Is Associated With Worse Overall Survival in Resected Pancreatic Adenocarcinoma.

Davis-Yadley AH, Abbott AM, Pimiento JM, Chen DT, Malafa MP.

Pancreas. 2016 Aug;45(7):974-9. doi: 10.1097/MPA.0000000000000580.

31.

Metabolic Activity by 18F-FDG-PET/CT Is Prognostic for Stage I and II Pancreatic Cancer.

Pimiento JM, Davis-Yadley AH, Kim RD, Chen DT, Eikman EA, Berman CG, Malafa MP.

Clin Nucl Med. 2016 Mar;41(3):177-81. doi: 10.1097/RLU.0000000000001098.

32.

Outcomes of a Clinical Pathway for Borderline Resectable Pancreatic Cancer.

Rashid OM, Pimiento JM, Gamenthaler AW, Nguyen P, Ha TT, Hutchinson T, Springett G, Hoffe S, Shridhar R, Hodul PJ, Johnson BL, Illig K, Armstrong PA, Centeno BA, Fulp WJ, Chen DT, Malafa MP.

Ann Surg Oncol. 2016 Apr;23(4):1371-9. doi: 10.1245/s10434-015-5006-1. Epub 2015 Dec 10.

PMID:
26661409
33.

Vitamins in pancreatic cancer: a review of underlying mechanisms and future applications.

Davis-Yadley AH, Malafa MP.

Adv Nutr. 2015 Nov 13;6(6):774-802. doi: 10.3945/an.115.009456. Print 2015 Nov. Review.

34.

Robotic Whipple Procedure for Pancreatic Cancer: The Moffitt Cancer Center Pathway.

Rashid OM, Mullinax JE, Pimiento JM, Meredith KL, Malafa MP.

Cancer Control. 2015 Jul;22(3):340-51. Review.

PMID:
26351891
35.

Radiosensitivity index predicts for survival with adjuvant radiation in resectable pancreatic cancer.

Strom T, Hoffe SE, Fulp W, Frakes J, Coppola D, Springett GM, Malafa MP, Harris CL, Eschrich SA, Torres-Roca JF, Shridhar R.

Radiother Oncol. 2015 Oct;117(1):159-64. doi: 10.1016/j.radonc.2015.07.018. Epub 2015 Jul 30.

PMID:
26235848
36.

EGR-1/Bax pathway plays a role in vitamin E δ-tocotrienol-induced apoptosis in pancreatic cancer cells.

Wang C, Husain K, Zhang A, Centeno BA, Chen DT, Tong Z, Sebti SM, Malafa MP.

J Nutr Biochem. 2015 Aug;26(8):797-807. doi: 10.1016/j.jnutbio.2015.02.008. Epub 2015 Apr 1.

37.

Defining borderline resectable pancreatic cancer: emerging consensus for an old challenge.

Malafa MP.

J Natl Compr Canc Netw. 2015 May;13(5):501-4. No abstract available.

PMID:
25964634
38.

Selective Nuclear Export Inhibitor KPT-330 Enhances the Antitumor Activity of Gemcitabine in Human Pancreatic Cancer.

Kazim S, Malafa MP, Coppola D, Husain K, Zibadi S, Kashyap T, Crochiere M, Landesman Y, Rashal T, Sullivan DM, Mahipal A.

Mol Cancer Ther. 2015 Jul;14(7):1570-81. doi: 10.1158/1535-7163.MCT-15-0104. Epub 2015 May 1.

39.

CDX2 protein expression compared to alcian blue staining in the evaluation of esophageal intestinal metaplasia.

Johnson DR, Abdelbaqui M, Tahmasbi M, Mayer Z, Lee HW, Malafa MP, Coppola D.

World J Gastroenterol. 2015 Mar 7;21(9):2770-6. doi: 10.3748/wjg.v21.i9.2770.

40.

Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma.

Mellon EA, Hoffe SE, Springett GM, Frakes JM, Strom TJ, Hodul PJ, Malafa MP, Chuong MD, Shridhar R.

Acta Oncol. 2015 Jul;54(7):979-85. doi: 10.3109/0284186X.2015.1004367. Epub 2015 Mar 3.

PMID:
25734581
41.

Comparative long-term outcomes of upfront resected pancreatic cancer after preoperative biliary drainage.

Strom TJ, Klapman JB, Springett GM, Meredith KL, Hoffe SE, Choi J, Hodul P, Malafa MP, Shridhar R.

Surg Endosc. 2015 Nov;29(11):3273-81. doi: 10.1007/s00464-015-4075-3. Epub 2015 Jan 29.

42.

Resected pancreatic cancer outcomes in the elderly.

Frakes JM, Strom T, Springett GM, Hoffe SE, Balducci L, Hodul P, Malafa MP, Shridhar R.

J Geriatr Oncol. 2015 Mar;6(2):127-32. doi: 10.1016/j.jgo.2014.11.005. Epub 2014 Dec 30.

PMID:
25555451
43.

Annexin A8 Is a Prognostic Marker and Potential Therapeutic Target for Pancreatic Cancer.

Pimiento JM, Chen DT, Centeno BA, Davis-Yadley AH, Husain K, Fulp WJ, Wang C, Zhang A, Malafa MP.

Pancreas. 2015 Jan;44(1):122-7. doi: 10.1097/MPA.0000000000000218.

44.

Hepatobiliary cancers, version 2.2014.

Benson AB 3rd, D'Angelica MI, Abrams TA, Are C, Bloomston PM, Chang DT, Clary BM, Covey AM, Ensminger WD, Iyer R, Kelley RK, Linehan D, Malafa MP, Meranze SG, Park JO, Pawlik T, Posey JA, Scaife C, Schefter T, Sigurdson ER, Tian GG, Vauthey JN, Venook AP, Yen Y, Zhu AX, Hoffmann KG, McMillian NR, Sundar H.

J Natl Compr Canc Netw. 2014 Aug;12(8):1152-82.

PMID:
25099447
45.

Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines.

Tempero MA, Malafa MP, Behrman SW, Benson AB 3rd, Casper ES, Chiorean EG, Chung V, Cohen SJ, Czito B, Engebretson A, Feng M, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Lowy AM, Ma WW, Merchant NB, Mulvihill SJ, Muscarella P 2nd, Nakakura EK, Obando J, Pitman MB, Reddy S, Sasson AR, Thayer SP, Weekes CD, Wolff RA, Wolpin BM, Burns JL, Freedman-Cass DA.

J Natl Compr Canc Netw. 2014 Aug;12(8):1083-93.

PMID:
25099441
46.

Adjuvant radiotherapy and lymph node dissection in pancreatic cancer treated with surgery and chemotherapy.

Mellon EA, Springett GM, Hoffe SE, Hodul P, Malafa MP, Meredith KL, Fulp WJ, Zhao X, Shridhar R.

Cancer. 2014 Apr 15;120(8):1171-7. doi: 10.1002/cncr.28543. Epub 2014 Jan 3.

47.

Vitamin E δ-tocotrienol prolongs survival in the LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre (KPC) transgenic mouse model of pancreatic cancer.

Husain K, Centeno BA, Chen DT, Hingorani SR, Sebti SM, Malafa MP.

Cancer Prev Res (Phila). 2013 Oct;6(10):1074-83. doi: 10.1158/1940-6207.CAPR-13-0157. Epub 2013 Aug 20.

48.

Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated.

Chuong MD, Springett GM, Freilich JM, Park CK, Weber JM, Mellon EA, Hodul PJ, Malafa MP, Meredith KL, Hoffe SE, Shridhar R.

Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):516-22. doi: 10.1016/j.ijrobp.2013.02.022. Epub 2013 Apr 5.

PMID:
23562768
49.

Vitamin E δ-tocotrienol induces p27(Kip1)-dependent cell-cycle arrest in pancreatic cancer cells via an E2F-1-dependent mechanism.

Hodul PJ, Dong Y, Husain K, Pimiento JM, Chen J, Zhang A, Francois R, Pledger WJ, Coppola D, Sebti SM, Chen DT, Malafa MP.

PLoS One. 2013;8(2):e52526. doi: 10.1371/journal.pone.0052526. Epub 2013 Feb 5.

50.

Prolonged survival and delayed progression of pancreatic intraepithelial neoplasia in LSL-KrasG12D/+;Pdx-1-Cre mice by vitamin E δ-tocotrienol.

Husain K, Centeno BA, Chen DT, Fulp WJ, Perez M, Zhang Lee G, Luetteke N, Hingorani SR, Sebti SM, Malafa MP.

Carcinogenesis. 2013 Apr;34(4):858-63. doi: 10.1093/carcin/bgt002. Epub 2013 Jan 9.

Supplemental Content

Loading ...
Support Center